FLEXOMICS LLC
Advancing single-cell biology with integrated imaging and sequencing
WALTHAM, United States · Founded 2020 · $8.4M raised
- Headquarters
- WALTHAM, Massachusetts
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- flexomics.com
- Total Funding
- $8.4M
- Last Round
- $2.0M GrantFeb 2024
- Rounds
- 3
About
Flexomics develops an integrated platform combining high-resolution fluorescence microscopy with single-cell sequencing to enable simultaneous functional and genomic analysis of hundreds of thousands of individual cells. Their FLEX picowell chip allows researchers to miniaturize cellular assays and link visual phenotypic features with genomic data in a single end-to-end workflow.
Summary
FLEXOMICS LLC is a Biotech company based in WALTHAM, United States, founded in 2020. It has raised $8.4M in total across 3 rounds, most recently a $2.0M Grant round in Feb 2024. Investors include National Cancer Institute and HHS.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.